Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells

Molecular Medicine Reports

Volumn 15, Issue 2, 2017, Pages 885-889

  Bai, Yu ^a   Yang, Hong ^a   Zhang, Guoying ^a   Hu, Libing ^a   Lei, Yonghong ^a   Qin, Yang ^a   Yang, Yong ^a   Wang, Qilin ^a   Li, Ruiqian ^a   Mao, Qiqi ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bladder cancer; Invasion; Matrix metalloproteinase; Migration; Resveratrol

Indexed keywords

FIBRONECTIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; TUMOR INVASION; WESTERN BLOTTING; BLADDER; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PREVENTION AND CONTROL; TUMOR CELL LINE; URINARY BLADDER NEOPLASMS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHORYLATION; STILBENES; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 85009104981     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.6051     Document Type: Article

References (29)

1. Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65: 5-29, 2015.
2. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, et al: Bladder cancer: Epidemiology, staging, and grading and diagnosis. Urology 66 (Suppl 6): S4-S34, 2005.
3. Khan N, Afaq F, Saleem M, Ahmad N and Mukhtar H: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66: 2500-2505, 2006.
4. Hosono T, Fukao T, Ogihara J, Ito Y, Shiba H, Seki T and Ariga T: Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. J Biol Chem 280: 41487-41493, 2005.
5. Zhu Y, Wu J, Li S, Wang X, Liang Z, Xu X, Xu X, Hu Z, Lin Y, Chen H, et al: Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer. Mol Med Rep 11: 1004-1008, 2015.
6. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY and Sun AY: Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958: 439-447, 2002.
7. Russo A, Palumbo M, Aliano C, Lempereur L, Scoto G and Renis M: Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sci 72: 2369-2379, 2003.
8. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
9. Clément MV, Hirpara JL, Chawdhury SH and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002, 1998.
10. Aziz MH, Nihal M, Fu VX, Jarrard DF and Ahmad N: Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 5: 1335-1341, 2006.
11. Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ and Lin HY: Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5: 2034-2042, 2006.
12. Tessitore L, Davit A, Sarotto I and Caderni G: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21: 1619-1622, 2000.
13. Sun Y, Wang H, Liu M, Lin F and Hua J: Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein. Mol Med Rep 11: 1975-1981, 2015.
14. Gao Q, Yuan Y, Gan HZ and Peng Q: Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis. Oncol Lett 9: 2381-2387, 2015.
15. Jiao Y, Li H, Liu Y, Guo A, Xu X, Qu X, Wang S, Zhao J, Li Y and Cao Y: Resveratrol inhibits the invasion of glioblastoma-initiating cells via down-regulation of the PI3K/Akt/NF-κB signaling pathway. Nutrients 7: 4383-4402, 2015.
16. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
17. Mook OR, Frederiks WM and Van Noorden CJ: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004.
18. Steeg PS: Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 12: 895-904, 2006.
19. Zhang L, Shi J, Feng J, Klocker H, Lee C and Zhang J: Type IV collagenase (matrix metalloproteinase-2 and-9) in prostate cancer. Prostate Cancer Prostatic Dis 7: 327-332, 2004.
20. Kader AK, Liu J, Shao L, Dinney CP, Lin J, Wang Y, Gu J, Grossman HB and Wu X: Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. Clin Cancer Res 13: 2614-2620, 2007.
21. Qin J, Wang Y, Bai Y, Yang K, Mao Q, Lin Y, Kong D, Zheng X and Xie L: Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-κB-mediated matrix metalloproteinase-9 expression. Mol Med Rep 6: 1040-1044, 2012.
22. Waas ET, Wobbes T, Lomme RM, DeGroot J, Ruers T and Hendriks T: Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90: 1556-1564, 2003.
23. Guruvayoorappan C and Kuttan G: Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 30: 711-727, 2008.
24. Reddy KB, Nabha SM and Atanaskova N: Role of MAP kinase in tumor progression and invasion. Cancer Metastas Rev 22: 395-403, 2003.
25. Crowe DL, Tsang KJ and Shemirani B: Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. Neoplasia 3: 27-32, 2001.
26. Moon SK, Kim HM, Lee YC and Kim CH: Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression. J Biol Chem 279: 33063-33070, 2004.
27. Wang BW, Chang H, Lin S, Kuan P and Shyu KG: Induction of matrix metalloproteinases-14 and-2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells. Cardiovasc Res 59: 460-469, 2003.
28. Lee SJ, Cho SC, Lee EJ, Kim S, Lee SB, Lim JH, Choi YH, Kim WJ and Moon SK: Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-κB) activation by inducing the up-regulation of p21(WAF1) protein expression. J Biol Chem 288: 5539-5552, 2013.
29. Gong Y, Qiu W, Ning X, Yang X, Liu L, Wang Z, Lin J, Li X and Guo Y: CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration. Oncotarget 6: 25856-25867, 2015.